Europe Medical Cannabis Market Growth, Size, Trends, Demand, Revenue, Share and Future Outlook

Europe Medical Cannabis Market Size- By Species, By Derivative, By Application, By End User, By Route of Administration- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Europe Medical Cannabis Market Size- By Species, By Derivative, By Application, By End User, By Route of Administration- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: May 2024 Report ID: PHAR2408 Pages: 1 - 153 Formats*:     
Category : Pharmaceutical
Europe Medical Cannabis Market Introduction and Overview 

According to SPER Market Research, the Europe Medical Cannabis Market is estimated to reach USD 58.11 billion by 2033 with a CAGR of 24.3%.

The report includes an in-depth analysis of the Europe Medical Cannabis Market, including market size and trends, product mix, distribution channels, and supplier analysis. The cannabis plant, which belongs to the Cannabaceae family, is the source of the psychoactive substance known as cannabis. It is used medicinally and has been for a while. Treatments for chronic pain, cancer, depression, diabetes, glaucoma, arthritis, migraines, AIDS, and Alzheimer's are just a few of the conditions for which it is used.

  • Tilray declared in May 2020 that it had obtained GMP certification in accordance with EU regulations, enabling the establishment to produce medical cannabis extracts on-site and export completed medical cannabis products. This facilitated the company's growth.
  •  Sanity Group GmbH, a division of Sanity Medical, and Telaleaf, a telemedicine platform, signed a partnership in February 2022 to advance telemedicine in cannabis therapy in Germany.
Europe Medical Cannabis Market
Market Opportunities and Challenges

Opportunities: One of the primary factors supporting a favorable market outlook is the rising incidence of chronic illnesses like cancer, arthritis, Alzheimer's, and migraines. Moreover, the industry is expanding due to the increased use of medical cannabis for pain relief. To numb pain receptors and give patients immediate comfort, it is typically smoked, inhaled, taken orally, or used topically. Furthermore, the legalization of medicinal marijuana in Europe has improved the products' accessibility through medical facilities and licensed outlets, which has fueled market expansion. It is projected that additional factors will propel the market, such as intensive research and development (R&D) efforts aimed at optimizing the use of cannabinoids and advancements in the healthcare infrastructure.

Challenges: Effects of Cannabis Use and Overuse: Short- and Long-Term Side Effects Following the use of the implants and drugs, orthopedic professionals note certain hazards. Complications from surgery or an implant gone wrong are delivered by the knee replacement surgeries. Among the most serious side effects following knee surgery is a loose implant; discomfort is the most frequent one. Serious falls, instability, and fractures of the bones can result from loosening. Surgery for revision is necessary for almost all major problems. Mechanical concerns, physical pain, and loosening of the knee implant are the risks.

Europe Medical Cannabis Market


Market Competitive Landscape
The Medical Cannabis market in Europe is moderately consolidated. Some of the market key players are Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION.

Scope of the Report:
 Report Metric Details
 Market size available for years 2020-2033
 Base year considered 2023
 Forecast period 2024-2033
 Segments coveredBy Species, By Derivative, By Application, By End Use, By Route of Administration
 Regions covered
UK, France, Germany, Italy, Spain, Rest of Europe
 Companies CoveredTilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, CANNARAY, and Sanity Group GmbH among others
COVID-19 Impact on Europe Medical Cannabis Market
The COVID-19 epidemic had a major effect on Europe's medical cannabis business, posing both opportunities and obstacles. Lockdowns and other regulations originally caused supply chains to break and made it more difficult for patients to obtain medical cannabis products, but they also led to changes in regulations and a rise in the adoption of telemedicine consultations, which made medical cannabis more widely accessible to those in need. Additionally, some European nations accelerated the legalization or development of medicinal cannabis programs in an effort to profit from the industry's potential economic benefits as governments looked for cash sources to lessen economic downturns.
 
Key Target Audience:
  •  Healthcare Professionals
  •  Patients and Caregivers
  •  Government Regulators and Policymakers
  •  Medical Cannabis Producers and Distributors
  •  Pharmaceutical Companies
  •  Research Institutions and Academia
Our in-depth analysis of the Europe Medical Cannabis Market includes the following segments:
By Species:
  • Indica
  • Sativa
  • Hybrid
  • By Derivative:
  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others
  • By Application:
  • Cancer
  • Arthritis
  • Migraine
  • Epilepsy
  • Others
  • By End Use:
  • Pharmaceutical Industry
  • Research and Development Centers
  • Others
  • By Route of Administration:
  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others
  • Key Topics Covered in the Report:
    •  Europe Medical Cannabis Market Size (FY’2024-FY’2033)
    •  Overview of Europe Medical Cannabis Market
    •  Segmentation of Europe Medical Cannabis Market By Species (Indica, Sativa, Hybrid)
    •  Segmentation of Europe Medical Cannabis Market By Derivative (Cannabidiol Tetrahydrocannabinol Others)
    •  Segmentation of Europe Medical Cannabis Market By Application (Cancer, Arthritis, Migraine, Epilepsy, Others)
    •  Segmentation of Europe Medical Cannabis Market By End Use (Pharmaceutical Industry, Research and Development Centers, Others)
    •  Expansion Analysis of Europe Medical Cannabis Market
    •  Problems and Obstacles in Europe Medical Cannabis Market
    •  Competitive Landscape in the Europe Medical Cannabis Market
    •  Impact of COVID-19 and Demonetization on Europe Medical Cannabis Market
    •  Details on Current Investment in Europe Medical Cannabis Market
    •  Competitive Analysis of Europe Medical Cannabis Market
    •  Prominent Players in the Europe Medical Cannabis Market
    •  SWOT Analysis of Europe Medical Cannabis Market
    •  Europe Medical Cannabis Market Future Outlook and Projections (FY’2024-FY’2033)
    •  Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Europe Medical Cannabis Market 

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Europe Medical Cannabis Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Medical Cannabis Market 

    7. Europe Medical Cannabis Market, By Species (USD Million) 2020-2033
    7.1. Europe Medical Cannabis Market Size, Share and Forecast, By Species, 2020-2026 
    7.2. Europe Medical Cannabis Market Size, Share and Forecast, By Species, 2027-2033
    7.3. Indica
    7.4. Sativa
    7.5. Hybrid

    8. Europe Medical Cannabis Market, By Derivative (USD Million) 2020-2033
    8.1. Europe Medical Cannabis Market Size, Share and Forecast, By Derivative, 2020-2026 
    8.2. Europe Medical Cannabis Market Size, Share and Forecast, By Derivative, 2027-2033
    8.3. Cannabidiol (CBD)
    8.4. Tetrahydrocannabinol (THC)
    8.5. Others

    9. Europe Medical Cannabis Market, By Application (USD Million) 2020-2033
    9.1. Europe Medical Cannabis Market Size, Share and Forecast, By Application, 2020-2026 
    9.2. Europe Medical Cannabis Market Size, Share and Forecast, By Application, 2027-2033
    9.3. Cancer
    9.4. Arthritis
    9.5. Migraine
    9.6. Epilepsy
    9.7. Others

    10. Europe Medical Cannabis Market, By End Use (USD Million) 2020-2033
    10.1. Europe Medical Cannabis Market Size, Share and Forecast, By End Use, 2020-2026 
    10.2. Europe Medical Cannabis Market Size, Share and Forecast, By End Use, 2027-2033
    10.3. Pharmaceutical Industry
    10.4. Research and Development Centers
    10.5. Others

    11. Europe Medical Cannabis Market, By Route of Administration (USD Million) 2020-2033
    11.1. Europe Medical Cannabis Market Size, Share and Forecast, By Route of Administration, 2020-2026 
    11.2. Europe Medical Cannabis Market Size, Share and Forecast, By Route of Administration, 2027-2033
    11.3. Oral Solutions and Capsules
    11.4. Smoking
    11.5. Vaporizers
    11.6. Topicals
    11.7. Others

    12. Europe Medical Cannabis Market Forecast, 2020-2033 (USD Million)
    12.1. Europe Medical Cannabis Market Size and Market Share

    13. Europe Medical Cannabis Market, By Region, 2020-2033 (USD Million)
    13.1. Europe Medical Cannabis Market Size and Market Share By Region (2020-2026)
    13.2. Europe Medical Cannabis Market Size and Market Share By Region (2027-2033)
    13.3. France 
    13.4. Germany 
    13.5. Italy 
    13.6. United Kingdom 
    13.7. Rest of Europe 

    14. Company Profile
    14.1. Althea Company Pty Ltd
    14.1.1. Company details
    14.1.2. Financial outlook
    14.1.3. Product summary 
    14.1.4. Recent developments
    14.2. Aurora Cannabis Inc.
    14.2.1. Company details
    14.2.2. Financial outlook
    14.2.3. Product summary 
    14.2.4. Recent developments
    14.3. CANOPY GROWTH CORPORATION
    14.3.1. Company details
    14.3.2. Financial outlook
    14.3.3. Product summary 
    14.3.4. Recent developments
    14.4. CANNARAY
    14.4.1. Company details
    14.4.2. Financial outlook
    14.4.3. Product summary 
    14.4.4. Recent developments
    14.5. EcoGen Biosciences
    14.5.1. Company details
    14.5.2. Financial outlook
    14.5.3. Product summary 
    14.5.4. Recent developments
    14.6. GRASS & CO.
    14.6.1. Company details
    14.6.2. Financial outlook
    14.6.3. Product summary 
    14.6.4. Recent developments
    14.7. Jazz Pharmaceuticals, Inc.
    14.7.1. Company details
    14.7.2. Financial outlook
    14.7.3. Product summary 
    14.7.4. Recent developments
    14.8. PharmaHemp
    14.8.1. Company details
    14.8.2. Financial outlook
    14.8.3. Product summary 
    14.8.4. Recent developments
    14.9. Sanity Group GmbH
    14.9.1. Company details
    14.9.2. Financial outlook
    14.9.3. Product summary 
    14.9.4. Recent developments
    14.10. Tilray
    14.10.1. Company details
    14.10.2. Financial outlook
    14.10.3. Product summary 
    14.10.4. Recent developments
    14.11. Others 
     
    17. Conclusion

    15. List of Abbreviations

    16. Reference Links

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    "Surgery for revision is necessary for almost all major problems. Mechanical concerns, physical pain, and loosening of the knee implant are the risks. "
    Europe Medical Cannabis Market is projected to reach USD 58.11 billion by 2033, growing at a CAGR of 24.3% during the forecast period.
    Europe Medical Cannabis Market size from 2022. The Market is expected to reach USD 58.11 billion by 2033, at a CAGR of 24.3% during the forecast period.
    Europe Medical Cannabis Market CAGR of 24.3% during the forecast period.
    Europe Medical Cannabis Market size is 58.11 billion from 2024 to 2033.
    Europe Medical Cannabis Market Segment is covered By Species, By Derivative, By Application, By End Use, By Route of Administration
    The Europe anticipated to have the highest market share in the Europe Medical Cannabis Market.
    The key players in the market include Companies Covered Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, CANNARAY, and Sanity Group GmbH among others.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 3400
    • 20% off
               
      $ 4520
    • 25% off
           
      $ 5650
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650